Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Hemispherx Biopharma Inc (HEB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7341
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), kidney cancer and metastatic malignant melanoma; multiple sclerosis, hepatitis C, HIV, west Nile virus, and SARS; and Alferon LDO (Low Dose Oral), an oral form of Alferon N Injection for influenza viruses. The company operates production facility in New Brunswick, New Jersey. Hemispherx is headquartered in Orlando, Florida, the US.

Hemispherx Biopharma Inc (HEB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc – Key Competitors 14
Hemispherx Biopharma Inc – Key Employees 15
Hemispherx Biopharma Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 15, 2018: Hemispherx announces six months ended June 30, 2018 financial results 17
May 16, 2018: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update 18
Apr 02, 2018: Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017 19
Nov 15, 2017: Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017 20
Product News 21
May 14, 2018: Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum 21
Aug 04, 2017: Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Hemispherx Biopharma Inc, Medical Equipment, Key Facts, 2017 2
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc, Key Competitors 14
Hemispherx Biopharma Inc, Key Employees 15
Hemispherx Biopharma Inc, Other Locations 16
Hemispherx Biopharma Inc, Subsidiaries 16

List of Figures
Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • B3 S.A.
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Reliv International Inc (RELV):企業の財務・戦略的SWOT分析
    Summary Reliv International Inc (Reliv) is a nutrition company that develops, manufactures and markets nutritional supplements for basic nutrition, specific wellness needs, weight management and sports nutrition. The company’s products include Reliv Classic and Reliv NOW, a nutritional supplement wi …
  • EVN AG:企業の発電所・SWOT分析2018
    EVN AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Grupo Posadas Sab De Cv
    Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report Summary Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Central Japan Railway Company:企業の戦略・SWOT・財務情報
    Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Denizbank A.S.
    Denizbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Denizbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Deutsche Telekom AG (DTE):企業の財務・戦略的SWOT分析
    Deutsche Telekom AG (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Kien Long Commercial Joint Stock Bank (KBC):企業の戦略的SWOT分析
    Kien Long Commercial Joint Stock Bank (KBC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins MWG Operon LLC (Eurofins) is a DNA sequencing service provider. The company offers DNA sequencing services, DNA synthesis products, and bioinformatic services. Its product categories comprise DNA and RNA synthesis, DNA sequencing, GENE synthesis and next gen seq. Eurofins provides n …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Jumboking Foods Pvt. Ltd.:企業の戦略・SWOT・財務分析
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Everest Industries Ltd:企業の戦略・SWOT・財務情報
    Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Virgin Atlantic Airways Ltd:企業の戦略・SWOT・財務情報
    Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mironid Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discove …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆